Offering you a complete choice of products which include finasteride tablets ip 1mg fast drop shipping, leading export drop shipping for finasteride tablets ip 1mg fast drop shipping to canberra, leading export drop shipping for finasteride tablets ip 1mg fast drop shipping to los angeles, leading export drop shipping for finasteride tablets ip 1mg fast drop shipping to rome, leading export drop shipping for finasteride tablets ip 1mg fast drop shipping to turin and leading export drop shipping for finasteride tablets ip 1mg fast drop shipping to houston.
₹ 200 / Strip Get Latest Price
| Strength | 1 mg |
| Brand | Fincepia |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Form | Tablet |
| Manufacturer | Cipla |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Manufacturer | Cipla |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Manufacturer | Cipla |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 200 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 200 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 420 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
Finpecia was approved initially in 1992 as Proscar, a treatment for enlarged prostate, but the sponsor had studied 1 mg of Finpecia and demonstrated hair growth in male pattern hair loss. Merck sells it under the brand name Propecia.
Health organisations and practising clinicians have expressed concerns that Propecia gives rise to persistent side-effects in some men.
Drop Shipping by Pharmacy Dropshipping in UK– Indian Medicine Exporter | Novasky Overseas Pvt. Ltd.
Pharmacy Dropshipping in UK – Indian Medicine Exporter | Novasky Overseas Pvt. Ltd.
DescriptionPharmacy Dropshipping in UK– Wholesale Medicine Exporter from India
Novasky Overseas Pvt. Ltd. is a leading name in pharmacy dropshipping services in Australia. With over a decade of global experience, we help pharmacies, clinics, and online medical retailers in Itley access WHO-GMP certified Indian medicines directly through our efficient dropshipping model.
Why Choose Novasky Overseas Pvt. Ltd. for Dropshipping to UK?
✅ No Inventory Hassles – medicines delivered directly to your customers.
✅ WHO-GMP Certified Products meeting global safety and quality standards.
✅ Competitive Pricing for pharmacies and bulk buyers.
✅ Private Label Support for custom branding.
✅ Safe & Reliable International Shipping to all major UK cities.
Products We Supply:
Erectile Dysfunction Medicines (Sildenafil, Tadalafil, Vardenafil)
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Prescription Required | Yes |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
₹ 400 / Strip Get Latest Price
| Strength | 1 mg |
| Manufacturer | Cipla |
| Packaging Size | 150 Tablets |
| Treatment | Hair Loss |
| Composition | Finasteride Only |
| Form | Tablet |
| Packaging Type | Box |
Finpecia is a synthetic antiandrogen that acts by inhibiting type II 5-alpha reductase, the enzyme that converts to (DHT). It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses.
A May, 2008 study indicates that Finpecia reduces the rate of prostate cancer by 30%. It is also indicated for use in combination with therapy to reduce the risk for symptomatic progression of BPH. In addition, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
Novasky Overseas (CEO)
Novasky Overseas
Plot No. 547, House No. 731, Dr Ambedkar Chowk, Shree Kachha Patidar Samaj Wadi, Garoba Nagar
Bagadganj, Nagpur - 440008, Maharashtra, India